Emergent BioSolutions (NYSE: EBS): Pioneering biopharmaceutical, strong buy
Emergent BioSolutions, Inc. (NYSE: EBS) is a pioneering global biopharmaceutical company dedicated to developing, manufacturing, and commercializing medical countermeasures to address a wide array of public health threats. Established on September 5, 1998, by Fuad El-Hibri, Emergent has since grown into a leading player in the field, with headquarters in Gaithersburg, Maryland.